BN Business News
Add your company to Business Communicator →

Business · 29/11/2010Updated: 10/17/2026 · 1 min read

FDA Releases Draft Guidance for In Vitro Diagnostic Devices to Detect Clostridium difficile

The Food and Drug Administration (FDA) has made available a draft guidance document outlining its recommendations for in vitro diagnostic devices intended to detect Clostridium difficile, a type of bacteria that causes diarrhea and colitis.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights

Business insights →